CELL AND GENE THERAPY INSIGHTS

Filter by Interests

Filter by ContentType

Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

K Bruce, K Bharti, I Barbaric et al
23 April 2025
Register
Achieving rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study

Achieving rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study

M Dingle, A Carwell, M J. Miller et al
08 April 2025
Register
GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

Lili Belcastro, Basak Clements, Claire Wartel
18 March 2025
Watch
Modernizing viral clearance study strategy: regulatory updates and industry best practices

Modernizing viral clearance study strategy: regulatory updates and industry best practices

Audrey Chang, Kathleen Kenney
25 February 2025
Watch
From concept to clinic: overcoming the challenges of potency assays in cell and gene therapy development

From concept to clinic: overcoming the challenges of potency assays in cell and gene therapy development

Audrey Chang, Joe Newcome
10 December 2024
Watch
Emerging global trends and regulatory opportunities in cell therapies for cancer

Emerging global trends and regulatory opportunities in cell therapies for cancer

Kim Watanabe, Sushama Sankpal, Kasey Kime
13 November 2024
Watch
Revolutionizing cell and gene therapy with digitalization: a panel discussion with industry leaders

Revolutionizing cell and gene therapy with digitalization: a panel discussion with industry leaders

Caitlin Harrison, Rebecca Street-Howards, Kanchan Deshpande
08 October 2024
Watch
Preventing cross-contamination in cell therapy production

Preventing cross-contamination in cell therapy production

Josh Ludwig, Mary Kay Bates
01 October 2024
Watch
Considerations in leveraging the Universal AAV Standard for dPCR to assess AAV genomes quantity and quality

Considerations in leveraging the Universal AAV Standard for dPCR to assess AAV genomes quantity and quality

Andrzej Noyszewski, Alex Deiulio
10 September 2024
Watch
Advancing viral vector manufacturing with innovation: the importance of the cell line

Advancing viral vector manufacturing with innovation: the importance of the cell line

Marguerite Campbell, Brian Tomkowicz
05 September 2024
Watch
Discover the road to success for viral vector production: strategies, insights, and regulatory considerations

Discover the road to success for viral vector production: strategies, insights, and regulatory considerations

Samira Shore, Anne Gilbert, Jesse Bishop
20 June 2024
Watch
Mastering the journey from initial method transfer to successful lot release for cell & gene therapies

Mastering the journey from initial method transfer to successful lot release for cell & gene therapies

A Chang, H Malicki, J Cheung et al
06 June 2024
Watch
Considerations to optimize and act upon long-term follow-up studies for cell and gene therapies

Considerations to optimize and act upon long-term follow-up studies for cell and gene therapies

K Wonnacott, L Pelloso, D Takefman et al
11 April 2024
Watch
Overcoming challenges in cell therapy production: rapid sterility testing

Overcoming challenges in cell therapy production: rapid sterility testing

Seth Peterson
13 March 2024
Watch
Strategic raw material selection for cell therapy commercialization

Strategic raw material selection for cell therapy commercialization

Kasey Kime, Lili Belcastro, Kyle Hondorp
09 November 2023
Watch
Pushing the boundaries of LNP production: an innovative analytical platform for evaluating vital LNP characteristics

Pushing the boundaries of LNP production: an innovative analytical platform for evaluating vital LNP characteristics

Nejc Pavlin
26 September 2023
Watch
How patient focus drives clinical trial results: the intersection of sponsor, CRO, site, and patient

How patient focus drives clinical trial results: the intersection of sponsor, CRO, site, and patient

K Kane, K Nealon, B Bratrude et al
07 September 2023
Watch
Exploring and overcoming the challenges of cell and gene-modified cell therapy CMC

Exploring and overcoming the challenges of cell and gene-modified cell therapy CMC

Julia Sable, Larry Bellot, Karen Doucette
25 July 2023
Watch
Regulatory considerations and validation strategies for mycoplasma testing for cell-based therapies

Regulatory considerations and validation strategies for mycoplasma testing for cell-based therapies

Michael Brewer
20 July 2023
Watch
Accelerating your gene therapy to patients: not all platforms are created equal

Accelerating your gene therapy to patients: not all platforms are created equal

George Buchman, Thomas VanCott
22 June 2023
Watch
How to increase speed from project initiation to IND filing for CGT products

How to increase speed from project initiation to IND filing for CGT products

Jennifer Cheung
08 June 2023
Watch